Oregon Health and Science UniversityPortland, Oregon Cancer Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, New York Robin L Jones, Vinod Ravi, Andrew S Brohl, Sant Chawla, Kristen N Ganjoo, Antoine Italiano, Steven Attia, Melissa A Burgess, Katherine Thornton, Lee D Cranmer, Maggie Chon U Cheang, Lingyun Liu, Liz Robertson, Bonne Adams, Charles Theuer, Robert G Maki, Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma, Jennifer A Lenz, Charles-Antoine Assenmacher, Victoria Costa, Katie L Louka, Suzanne Rau, Nicholas S. Keuler, Paul J. Zhang, Robert G. Maki, Amy C. Durham, Enrico Radaelli, Matthew J. Atherton. Heikki Joensuu, Javier Martin-Broto, Toshirou Nishida, Peter Reichardt, Patrick Schffski, Robert G. Maki, Psychological Distress of Internal Medicine Residents Rotating on a Hematology and Oncology Ward: An Exploratory Study of Patient Deaths, Personal Stress, and Attributed Meaning, Daniel C. McFarland, Robert G. Maki, Jimmie C. Holland, Key Issues in the Clinical Management of Gastrointestinal Stromal Tumors: An Expert Discussion, Robert G. Maki, Jean-Yves Blay, George D. Demetri, Jonathan A. Fletcher, Heikki Joensuu, Javier Martin-Broto, Toshirou Nishida, Peter Reichardt, Patrick Schffski, Jonathan C. Trent, Clinical activity of pazopanib in metastatic extraosseous ewing sarcoma, Steven Attia, Scott H. Okuno, Steven I. Robinson, Nicholas P. Webber, Daniel J. Indelicato, Robin L. Jones, Sanjay P. Bagaria, Courtney E. Sherman, Kevin R. Kozak, Cherise Cortese, Thomas McFarland, Jonathan C. Trent, Robert G. Maki. By agreeing to submit your resume, you consent (in accordance with our Terms of Use and Privacy Policy) to: Should you have any questions or wish have your information removed from our service, please contact us here. Accepting New Patients: Yes. Toulmonde M, Italiano A, Penel N, Cioffi A, Le Cesne A, Isambert N, Bompas E, Duffaud F, Patrikidou A, Maki RG, Coindre J, Blay J, Bui Nguyen B. Progression-free survival (PFS) from a phase I study of crizotinib (PF-02341066) in patients with ALK-positive non-small cell lung cancer (NSCLC). Rushing, Scott H. Okuno, Denise K. Reinke, Richard F. Riedel, Steven Attia, Leo Mascarenhas, Robert G. Maki, Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma: A Review. Although new laws and advocacy can make the cancer care system fairer and mortality differences by race are slowly narrowing the explosion in sophisticated new cancer drugs is at the same time pushing things in the other direction. Since metastatic disease was usually considered incurable, research focused on early-stage disease. University Overview The University of Pennsylvania, the largest private employer in Philadelphia, is a world-renowned le Do you want to receive a free, professional resume evaluation from TopResume? CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers. Gastrointestinal stromal tumors in children and young adults: a clinicopathologic, molecular, and genomic study of 15 cases and review of the literature. See all conditions on Dr. Maki's. Sorafenib for Advanced and Refractory Desmoid Tumors. Doctors do not know exactly why or how breast cancer can go dormant in a patients body for so long, not advancing for years, until it suddenly begins to grow. Comprehensive Cancer Center, Sanford Burnham Prebys Medical Discovery InstituteLa Jolla, California Cancer Center, Hollings Cancer Center Fletcher, Annick D. Van den Abbeele, Christopher L. Corless, Cristina R. Antonescu, Suzanne George, Jeffrey A. Morgan, Ming-Hui Chen, Carlo L. Bello, Xin Huang, Darrel P. Cohen, Charles M. Baum, Robert G. Maki, KDR Activating Mutations in Human Angiosarcomas Are Sensitive to Specific Kinase Inhibitors, Cristina R. Antonescu, Akihiko Yoshida, Tianhuo Guo, Ning-En Chang, Lei Zhang, Narasimhan P. Agaram, Li-Xuan Qin, Murray F. Brennan, Samuel Singer, Robert G. Maki. Abramson Cancer Center University of Pennsylvania Philadelphia, Pennsylvania Comprehensive Cancer Center. Robert J. Canter, Li-Xuan Qin, Robert G. Maki, Murray F. Brennan, Marc Ladanyi, Samuel Singer, EBV-Associated Smooth Muscle Neoplasms: Solid Tumors Arising in the Presence of Immunosuppression and Autoimmune Diseases, Kimberly Moore Dalal, Cristina R. Antonescu, Ronald P. DeMatteo, Robert G. Maki, Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor, Michael Heinrich, Robert G. Maki, Christopher L. Corless, Cristina R. Antonescu, Amy Harlow, Diana J. Griffith, Ajia Town, Arin McKinley, Wen-Bin Ou, Jonathan A. Fletcher, Christopher D.M. Chugh R, Maki RG, Thomas DG, Reinke D, Wathen JK, Patel S, Priebat DA, Meyers PA, Benjamin RS, Baker LH, Altered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate, Ellin Berman, Maria Nicolaides, Robert G. Maki, Martin Fleisher, Suzanne Chanel, Kelly Scheu, Bri-Anne Wilson, Glenn Heller, Nicholas P Sauter, Rachel P. Dubroff, Robert G. Maki, Klaus J. Busam, Dana L. Sachs, Phase II Study of Doxorubicin and Bevacizumab for Patients With Metastatic Soft-Tissue Sarcomas, David R. D'Adamo, Sibyl Anderson, Karen Albritton, Jennifer Yamada, Elyn Riedel, Kelly Scheu, Gary K. Schwartz, Helen Chen, Robert G. Maki, De novo osteogenic sarcoma in patients older than forty : benefit of multimodality therapy, Mark W. Manoso, John H. Healey, Patrick J. Boland, Edward A. Athanasian, Robert G. Maki, Andrew G. Huvos, Carol D. Morris. The role of DNA rearrangement and alternative RNA processing in the expression of immunoglobulin delta genes. The content on Healthgrades does not provide medical advice. Provide in-service and support to infusion, CHPS or inpatient staff as appropriate. Divalent cations regulate glucagon binding. New therapeutic targets in soft tissue sarcoma. This is a new paradigm. Abramson Cancer Center is a medical group practice located in Philadelphia, PA that specializes in Hematology and Medical Oncology. Robert G Maki, Patrick J Grohar, Cristina R Antonescu. Comprehensive Cancer Center, Herbert Irving Comprehensive Cancer Center Major new funded research efforts include germline and tumor-directed genomics efforts, focused efforts on mechanisms of DNA damage/repair and epigenomic aberrations in cancer, molecular target discovery and drug development efforts, and continued expansion of our clinical research program, especially investigator-initiated early phase clinical trials, with 158 currently open clinical research protocols. Treatment of advanced soft tissue sarcoma: efficacy and safety of trabectedin, a multitarget agent, and update on other systemic therapeutic options. What if it comes back? I asked my oncologist. Emanuela Palmerini, Robert G. Maki, Eric L. Staals, Marco Alberghini, Cristina R. Antonescu, Crisitina Ferrari, Pietro Ruggieri, Andreas F. Mavrogenis, Franco Bertoni, Marilena Cesari, Anna Paioli, Emanuela Marchesi, Piero Picci, Stefano Ferrari, A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: Results of a Sarcoma Alliance for Research Through Collaboration study, Alberto S. Pappo, Gilles Vassal, John Crowley, Vanessa Bolejack, Pancras C.W. Fritz C. Eilber, Murray F. Brennan, Frederick R. Eilber, Jeffery J. Eckardt, Stephen R. Grobmyer, Elyn Riedel, Charles Forscher, Robert G. Maki, Samuel Singer. Patterns of care, prognosis, and survival of patients with metastatic gastrointestinal stromal tumors (GIST) refractory to first-line imatinib and second-line sunitinib. Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy. Triage any questions subjects may have regarding protocol specifics, investigational products, lab results, effects of therapies, medications, and symptom management within clinical scope and level of expertise and referring other questions to the PI or medical team in order to obtain guidance or assistance. Comprehensive Cancer Center, Fox Chase Cancer CenterPhiladelphia, Pennsylvania Abramson Cancer Center Perelman 2nd Floor West - Penn Medicine Cancer Center, Memorial Sloan-Kettering Cancer CenterNew York, New York 3400 Civic Center Blvd, Philadelphia PA, 19104 Make an Appointment Show Phone Number Telehealth services available Abramson Cancer Center is a medical group practice located in Philadelphia, PA that specializes in Medical Oncology and Hematology. Richard F. Riedel, Robert G. Maki, Andrew J. Wagner, The cyclin-dependent kinase inhibitor flavopiridol potentiates doxorubicin efficacy in advanced sarcomas: preclinical investigations and results of a phase I dose escalation clinical trial, Jason J. Luke, David R. D'Adamo, Mark A. Dickson, Mary Louise Keohan, Richard D. Carvajal, Robert G. Maki, Elisa de Stanchina, Elgilda Musi, Samuel Singer, Gary K. Schwartz, Patterns of Care, Prognosis, and Survival in Patients with Metastatic Gastrointestinal Stromal Tumors (GIST) Refractory to First-Line Imatinib and Second-Line Sunitinib, Antoine Italiano, Angela Cioffi, P. Coco, Robert G. Maki, Patrick Schffski, Piotr Rutkowski, Axel Le Cesne, Florence Duffaud, Antoine Adenis, Nicolas Isambert, Emmanuelle Bompas, Jean-Yves Blay, Paolo G. Casali, Mary Louise Keohan, Maud Toulmonde, Cristina R. Antonescu, Maria Debiec-Rychter, Jean Michel Coindre, Binh Bui. Blay, N. Isambert, S. Piperno Neumann, C. Blay, E. Zanardi, Pascaline Boudou-Rouquette, Laurence Bozec, Florence Duffaud, Franois Bertucci, Antoine Italiano. Whats happening now is different. Work in collaboration with Research Team Leaders and Principal Investigators with initiating study procedures for new IITs and industry-sponsored clinical trials. Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST). Abramson Cancer Center, Philadelphia, PA, 19104, Hospitals of the University of Pennsylvania-Penn Presbyterian, High Performing in Colon Cancer Surgery, Lung Cancer Surgery, Ovarian Cancer Surgery and Prostate Cancer Surgery, Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute, Fellowship, Hematology and Medical Oncology, 1995-1998, FASCO (Fellow of the American Society of Clinical Oncology), 2018, TERT Promoter Mutations in Solitary Fibrous Tumor, Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology, Richard L. Schilsky, John Heymach, Robert G. Maki, Harold Burstein. The location you tried did not return a result. University of Texas Health Science CenterSan Antonio, Texas Meng RD, Qin L, Shelton CC, Li Y, Maki RG, Brill ER, Singer S, Schwartz GK. Baker LH, Wathen K, Chugh R, Thomas D, Thall PF, Maki RG, Samuels BL, Meyers PA, Priebat DA, Benjamin RS. PRIMARY LOCATION. Old, Pramod K. Srivastava. Comprehensive Cancer Center, Duke Cancer Institute WebMD does not provide medical advice, diagnosis or treatment. |, Abramson Cancer Center - Cancer Control Program, Healthy Eating study chosen as one of Penn Med's top health equity initiatives. IGF2 over-expression in solitary fibrous tumours is independent of anatomical location and is related to loss of imprinting. In a rapidly evolving healthcare landscape, methods of identifying the Best Hospitals evolve, too. CCCR Locations - Children's Hospital of Philadelphia Fletcher, John J. Crowley, Ernest C. Borden. Van Tine, Jonathan C. Trent, Shreyaskumar Patel, Andrew J. Wagner, Rashmi Chugh, John Heyburn, Susan C. Weil, Wenquan Wang, Kert Viele, Robert G. Maki, Expression of lymphocyte immunoregulatory biomarkers in bone and soft-tissue sarcomas, Amanda R. Dancsok, Nokitaka Setsu, Dongxia Gao, Jean-Yves Blay, David Thomas, Robert G. Maki, Torsten O. Nielsen, Elizabeth G Demicco. Philadelphia, PA 19104 . Cancer Center, University of Florida Health Cancer Center Participate in core study team, disease-site group and ongoing protocol training/compliance meetings. Cancer Center. This individual will work independently with minimal supervision. Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors. Rutgers Biomedical and Health SciencesNew Brunswick, New Jersey Structure-activity relationships of N-hydroxyurea 5-lipoxygenase inhibitors. D'Adamo DR, Scheu K, Singer S, Schwartz GK, Maki RG. Our Mission: At the Abramson Cancer Center we are dedicated to only one purpose- the eradication of cancer as a cause of human disease and suffering. Cancer Care Here and Now Find a Doctor Request an Appointment Find a Clinical Trial Clinical trials help cancer survivors live longer and have a better quality of life through new ways to detect, diagnose and treat cancer. ONeal Comprehensive Cancer Center The mission of the ACC Clinical Research Unit (CRU) is to advance the science of cancer care, serve our patients by improving clinical outcomes, and . Mon 8:30 am - 4:30 pm. Comprehensive Cancer Center, University of Hawaii Cancer CenterHonolulu, Hawaii In the eight years since, even more medicines have come on the market. Coordinate activities of oncology team in caring for subjects. Work directly with physicians to design, set-up and execute studies. If you have no effective treatments for cancer, it doesnt matter if you are a millionaire in the best health, because theres no treatment, said Dr. Lin, Carol MacKenzies doctor. Eva Hernando, Elizabeth Charytonowicz, Maria E. Dudas, Silvia Menendez, Igor Matushansky, Joslyn Mills, Nicholas D. Socci, Nille Behrendt, Li Ma, Robert G. Maki, Pier Paolo Pandolfi, Carlos Cordon-Cardo. Comprehensive Cancer Center, City of Hope Comprehensive Cancer CenterDuarte, California Demetri GD, Desai J, Fletcher JA, Morgan JA, Fletcher CDM, Kazanovicz A, Van Den Abbeele A, Baum C, Maki R, Heinrich MC, Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site, Cristina R. Antonescu, Agnes Viale, Lisa Sarran, Sylvia J. Tschernyavsky, Mithat Gonen, Neil H. Segal, Robert G. Maki, Nicholas D. Socci, Ronald P. DeMatteo, Peter Besmer, NCCN Task Force Report : Optimal management of patients with gastrointestinal stromal tumor (GIST)-expansion and update of NCCN clinical practice guidelines, George D. Demetri, Robert S. Benjamin, Charles D. Blanke, Haesun Choi, Chris Corless, Ronald P. DeMatteo, Burton L. Eisenberg, Christopher D.M. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements. Ronald P. DeMatteo, Karla V. Ballman, Cristina R. Antonescu, Robert G. Maki, Peter W.T. Multidisciplinary management of soft-tissue sarcomas. Radiation oncologists use multiple forms of radiation in an effort to eliminate tumors. Wayne State University School of MedicineDetroit, Michigan Philadelphia, PA 19104. The University of OklahomaOklahoma City, Oklahoma She knows that Trodelvy may eventually stop working for her and hopes that by then there will be a variety of other drugs and drug combinations available or being tested in clinical trials that will accept her for enrollment. Van Tine, Thierry Alcindor, Robin L. Jones, D. R. D'Adamo, Matthew Guo, Sant P. Chawla. Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer. Assist in analyzing clinical data to determine response and clinical outcomes; contribute to the preparation of study abstracts, posters, manuscripts and grant applications. This area of research requires dedicated attention and care to ensure subject safety and well-being. Gabriella N Tortorello, Cimarron E Sharon, Kevin L Ma, Nikhita Perry, Jacob E Shabason, Robert G Maki, John T Miura, Giorgos C Karakousis. A phase II trial of sorafenib (S) and dacarbazine (D) in leiomyosarcoma (LMS), synovial sarcoma (SS), and malignant peripheral nerve sheath tumor (MPNST). Monogenic and polygenic determinants of sarcoma risk: an international genetic study, Mandy L. Ballinger, David L Goode, Isabelle Ray-Coquard, Paul A. James, Gillian Mitchell, Eveline Niedermayr, Ajay Puri, Joshua D. Schiffman, Gillian S. Dite, Arcadi Cipponi, Robert G. Maki, Andrew S. Brohl, Ola Myklebost, Eva W. Stratford, Susanne Lorenz, Sung-Min Ahn, Jin Hee Ahn, Jeong Eun Kim, Sue Shanley, Victoria Beshay, Robert Lor Randall, Ian Judson, Beatrice Seddon, Ian G. Campbell, Mary-Anne Young, Rajiv Sarin, Jean-Yves Blay, Sen I. O'Donoghue, David Thomas, Contemporary Therapy for Advanced Soft-Tissue Sarcomas in Adults: A Review, Angela Pang, Mariana Carbini, Robert G. Maki, Development and clinical application of an integrative genomic approach to personalized cancer therapy, Andrew V. Uzilov, Wei Ding, Marc Y. Fink, Yevgeniy Antipin, Andrew S. Brohl, Claire R. Davis, Chun Yee Lau, Chetanya Pandya, Hardik Shah, Yumi Kasai, James C. Powell, Mark Micchelli, Rafael Castellanos, Zhongyang Zhang, Michael D. Linderman, Yayoi Kinoshita, Micol Zweig, Katie Raustad, Kakit Cheung, Diane Castillo, Melissa Wooten, Imane Bourzgui, Leah C. Newman, Gintaras Deikus, Bino Mathew, Jun Zhu, Benjamin S. Glicksberg, Aye S. Moe, Jun Liao, Lisa Edelmann, Joel T. Dudley, Robert G. Maki, Andrew Kasarskis, Randall F. Holcombe, Milind Mahajan, Ke Hao, Boris Reva, Janina Longtine, Daniela Starcevic, Robert Sebra, Michael J. Donovan, Shuyu Li, Eric E. Schadt, Rong Chen, Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial, Patrick Schffski, Sant P. Chawla, Robert G. Maki, Antoine Italiano, Hans Gelderblom, Edwin Choy, Giovanni Grignani, Veridiana Pires de Camargo, Sebastian Bauer, Sun Young Rha, Jean-Yves Blay, Peter Hohenberger, D. R. D'Adamo, Matthew Guo, Bartosz Chmielowski, Axel Le Cesne, George D. Demetri, Shreyaskumar Patel.

University Of Utah Married Housing, California 4th District Map, Articles A